Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0917801 (
insomnia
)
10,606
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The protein brain-derived neurotrophic factor (
BDNF
) is a member of the neurotrophin family of growth factors involved in plasticity of neurons in several brain regions. There are numerous evidence that
BDNF
expression is decreased by experiencing psychological stress and that, accordingly, a lack of neurotrophic support causes major depression. Furthermore, disruption in sleep homeostatic processes results in higher stress vulnerability and is often associated with stress-related mental disorders. Recently, we reported, for the first time, a relationship between
BDNF
and
insomnia
and sleep deprivation (SD). Using a biphasic stress model as explanation approach, we discuss here the hypothesis that chronic stress might induce a deregulation of the hypothalamic-pituitary-adrenal system. In the long-term it leads to sleep disturbance and depression as well as decreased
BDNF
levels, whereas acute stress like SD can be used as therapeutic intervention in some insomniac or depressed patients as compensatory process to normalize
BDNF
levels. Indeed, partial SD (PSD) induced a fast increase in
BDNF
serum levels within hours after PSD which is similar to effects seen after ketamine infusion, another fast-acting antidepressant intervention, while traditional antidepressants are characterized by a major delay until treatment response as well as delayed
BDNF
level increase. Key messages
Brain-derived neurotrophic factor
(
BDNF
) plays a key role in the pathophysiology of stress-related mood disorders. The interplay of stress and sleep impacts on
BDNF
level. Partial sleep deprivation (PSD) shows a fast action on
BDNF
level increase.
...
PMID:BDNF in sleep, insomnia, and sleep deprivation. 2675 1